Assessment of the GORE® EXCLUDER® Conformable AAA Endoprosthesis in the Treatment of Abdominal Aortic Aneurysms

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 175 participants.

Also called NCT02489539

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 175 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02489539
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT02489539. Non-randomized; no masking; primary purpose treatment. Start 2017-12-19 (actual); primary completion 2023-05-25 (actual). Results posted on 2024-04-04.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Assessment of the GORE® EXCLUDER® Conformable AAA Endoprosthesis in the Treatment of Abdominal Aortic Aneurysms
Condition
Aortic Aneurysm, Abdominal
Intervention (Device)
GORE® EXCLUDER® Conformable AAA Endoprosthesis
Lead sponsor
W.L.Gore & Associates (class: industry)

Record details

Record id
cardio:ct-nct02489539
Content hash
9b75297fd72c6044f7519c357a79df956faa7996b903eeeb50ffec7917871466